ホーム600535 • SHA
add
Tasly Pharmaceutical Group Co Ltd
前日の終値
¥14.54
日次変動幅
¥14.57 - ¥14.81
年間変動幅
¥12.24 - ¥17.77
時価総額
220.51億 CNY
平均取引高
869.04万
株価収益率
25.11
配当利回り
2.79%
優先市場
SHA
市場ニュース
財務情報
損益計算書
収益
純利益
(CNY) | 2024年9月info | 前年比変化率 |
---|---|---|
収益 | 20.91億 | -4.06% |
営業費用 | 10.28億 | -2.03% |
純利益 | 1.80億 | -44.67% |
純利益率 | 8.60 | -42.36% |
1 株当たりの収益 | — | — |
EBITDA | 4.42億 | -18.76% |
実効税率 | 14.16% | — |
貸借対照表
総資産
負債総額
(CNY) | 2024年9月info | 前年比変化率 |
---|---|---|
現金および短期投資 | 49.68億 | 13.35% |
総資産 | 168.35億 | -4.76% |
負債総額 | 38.17億 | -22.94% |
純資産 | 130.18億 | — |
発行済み株式 | 14.94億 | — |
帳簿価格 | 1.71 | — |
総資産利益率 | 4.92% | — |
資本利益率 | 5.52% | — |
キャッシュ フロー
現金の純増減額
(CNY) | 2024年9月info | 前年比変化率 |
---|---|---|
純利益 | 1.80億 | -44.67% |
営業キャッシュ フロー | 3.03億 | 22.05% |
投資キャッシュ フロー | -2.61億 | -362.16% |
財務キャッシュ フロー | -9.93億 | -2,032.67% |
現金の純増減額 | -9.52億 | -338.75% |
フリー キャッシュ フロー | -8.25億 | -1,070.21% |
概要
Tasly is a Chinese pharmaceutical company based in the city of Tianjin. It was established in 1994 and is notably producing traditional Chinese medicines.
It has a turnover of 4 billion US dollars, 10,000 employees and is listed on the Shanghai Stock Exchange.
In 2009, Chinese pharmacologist Li Lianda claimed that a key product made by Tasly was unsafe. Tasly sued Li in 2013, alleging that Li's claim was baseless and was motivated by his financial and employment relations with Guangzhou Pharmaceutical, a direct competitor of Tasly. In September 2014, the Tianjin High People's Court ruled in favour of Tasly and ordered Li to issue an apology and pay Tasly 300,000 yuan in compensation.
In February 2017, Tasly announced plans to form a joint venture with American multi-level marketing company Herbalife. Wikipedia
設立
1994
ウェブサイト
従業員数
9,223